Skip to main content
. Author manuscript; available in PMC: 2020 Mar 4.
Published in final edited form as: J Interv Card Electrophysiol. 2018 Oct 17;56(2):159–163. doi: 10.1007/s10840-018-0465-5

Fig. 1.

Fig. 1

The risk of stroke, with and without anticoagulation, are depicted using a visual representation of 100 patients, each with similar stroke risk based on CHA2DS2-VASc score. A representative proportion of this a population who would be expected to have either a fatal/disabling stroke or a non-disabling stroke are colored in yellow or purple. Individuals who would be spared an anticipated stroke with anticoagulation are colored in blue